Use of multiple surveillance modalities to assess the epidemiology of Streptococcus pneumoniae infection in Bangladesh

Clinical Infectious Diseases

Volumn 48, Issue SUPPL. 2, 2009, Pages

  Luby, Stephen P ^a   Brooks, W Abdullah ^a   Saha, Samir K ^b   El Arifeen, Shams ^a   Naheed, Aliya ^a   Sack, David ^a   Breiman, Robert F ^a,c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b DHAKA SHISHU HOSPITAL   (Bangladesh)

^c Centers for Disease Control   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

BANGLADESH; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; COMMUNITY ASSESSMENT; DISEASE SURVEILLANCE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; METHODOLOGY; MORTALITY; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; REVIEW; RURAL AREA; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

BANGLADESH; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; RURAL POPULATION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; URBAN POPULATION;

EID: 61849103999     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/596487     Document Type: Review

References (24)

1. World Health Organization. Pneumococcal vaccines. Wkly Epidemiol Rec 2003; 78:110-9.
2. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19:187-95.
3. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-8.
4. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46.
5. Hausdorff WP. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 2002; 161(Suppl 2):S135-9.
6. Saha SK, Baqui AH, Darmstadt GL, et al. Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol 2003; 41:5582-7.
7. Musa S. Bangladesh country paper. Daejeon, South Korea: Heads of National Statistical Offices in Asia and the Pacific, 2006.
8. National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ORC Macro. Bangladesh Demographic and Health Survey 2004. Dhaka, Bangladesh and Calverton, MD: NIPORT, Mitra and Associates, and ORC Macro, 2005.
9. Arifeen SE, Akhter T, Chowdhury HR, et al. Causes of death in children under five years of age: Bangladesh Demographic and Health Survey 2004. Dhaka, Bangladesh and Calverton, Maryland. National Institute of Population Research and Training, Mitra and Associates, and ORC Macro, 2004.
10. Population Reference Bureau. 2005 World population data sheet. Washington, DC: Population Reference Bureau, 2005.
11. Roca A, Sigauque B, Quinto L, et al. Invasive pneumococcal disease in children <5 years of age in rural Mozambique. Trop Med Int Health 2006; 11:1422-31.
12. Pebody RG, Hellenbrand W, D'Ancona F, Ruutu P. Pneumococcal disease surveillance in Europe. Euro Surveill 2006; 11:171-8.
13. Saha SK, Naheed A, Arifeen SE, et al. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin Infect Dis 2009; 48(Suppl 2):S75-81 (in this supplement).
14. Naheed A, Saha SK, Breiman RF, et al. Multihospital surveillance of pneumonia burden among children aged <5 years hospitalized for pneumonia in Bangladesh. Clin Infect Dis 2009; 48(Suppl 2):S82-9 (in this supplement).
15. Ahmed NU, Alam MM, Sultana F, Sayeed SN, Pressman AM, Powers MB. Reaching the unreachable: barriers of the poorest to accessing NGO healthcare services in Bangladesh. J Health Popul Nutr 2006; 24:456-66.
16. Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998; 17:986-91.
17. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations. II. Implications for conjugate vaccine formulation and use. Clin Infect Dis 2000; 30:122-40.
18. Brooks WA, Breiman RF, Goswami D, et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 2007; 77:795-801.
19. Gove S. Integrated management of childhood illness by outpatient health workers: technical basis and overview. World Health Organization Working Group on Guidelines for Integrated Management of the Sick Child. Bull WHO 1997; 75(Suppl 1):7-24.
20. United Nations Population Division. Urbanization patterns and rural population growth at the country level. In: World urbanization prospects. 2001 rev. New York: United Nations, 2001:50-74.
21. Arifeen SE, Saha SK, Rahman S, et al. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clin Infect Dis 2009; 48(Suppl 2):S103-13 (in this supplement).
22. O'Dempsey TJ, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of West Africa. Pediatr Infect Dis J 1996; 15:431-7.
23. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784-92.
24. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196:1346-54.